FDA Inspection 1084753 — Robert C. Doebele, MD, PhD
The FDA completed an inspection of Robert C. Doebele, MD, PhD on March 15, 2019 in Aurora, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 15, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Aurora, CO (United States)
Additional Details
Clinical Investigator (CI)